ASRS is an international, state-or-the-art event offering something for everyone: scientific papers, posters, panel discussions on controversial issues and techniques, award lectures, a Retina Case Conference, the 25th Annual Film Festival, international symposia, and subspecialty review courses.
The 41st annual meeting of the American Society of Retina Specialists will convene on Friday, July 28, and extend through Tuesday, August 1, 2023. The venue is the Seattle Conference Center at 705 Pike Street, Seattle.
This international state-of-the-art event offers something for everyone: scientific papers with question-and-answer sessions, scientific posters with the opportunity to speak with the authors, panel discussions on controversial issues and techniques, award lectures, a Retina Case Conference, the 25th Annual Film Festival, international symposia, and subspecialty review courses, according to Jill Blim, MS, ASRS Executive Vice President.
Other highlights to look for are the Early Career Section lunch (Saturday, July 29, 12:35-1:50 pm), the Women in Retina Case Conference (Sunday, July 30, 5:05-6:35 pm), and the Fellows-in-Training & Residents Reception at Daniel's Broiler in the Hyatt Regency Seattle (Saturday, July 29, 6:30-8:30 pm).
Registration for the conference is available online.
The following list shows the session titles. The full details and scheduled speakers are available at https://www.asrs.org/content/documents/pocket-guide-6.29.23.pdf
All times shown are in Pacific time. (PST)
The following awards will be presented during the ceremony on Monday, July 31, 11:25 am to 12:35 pm.
A wide selection of live and hybrid satellite symposia are listed below will take place in conjunction with the annual meeting. To register for these events, interested parties can use the links supplied. All times listed are Pacific Time. These events are not affiliated with ASRS.
Lunch symposia
Lunch symposia
Evening symposia
Breakfast symposia
Lunch symposium
The 2024 annual meeting of ASRS is scheduled to take place in Stockholm, Sweden, from July 17-20.
ASRS 2023: Efficacy/safety of biosimilars ranibizumab-nuna and ranibizumab-eqrn in clinical use
July 30th 2023This study of patients was designed to identify unexpected adverse effects of these new pharmacologic therapies that may not have been observed or anticipated during clinical research trials. The studied drugs were biosimilars to the reference drug ranibizumab.